DNTH - Dianthus Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DNTH is currently covered by 4 analysts with an average price target of $49.74. This is a potential upside of $14.76 (42.2%) from yesterday's end of day stock price of $34.98.

Dianthus Therapeutics's activity chart (see below) currently has 19 price targets and 20 ratings on display. The stock rating distribution of DNTH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.29% with an average time for these price targets to be met of 147 days.

Highest price target for DNTH is $63, Lowest price target is $40, average price target is $49.75.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 12-Sep-2025. First documented stock forecast 28-Sep-2023.

Best performing analysts who are covering DNTH - Dianthus Therapeutics:

Maury Raycroft Laura Chico Swayampakula Ramakanth Steven Seedhouse Leland Gershell

Currently out of the existing stock ratings of DNTH, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$44

$11.08 (33.66%)

$42

1 months 20 days ago
(12-Sep-2025)

5/7 (71.43%)

$6.84 (18.41%)

304

Buy

$63

$30.08 (91.37%)

$56

1 months 23 days ago
(09-Sep-2025)

1/4 (25%)

$27.43 (77.12%)

132

Buy

$40

$7.08 (21.51%)

$40

1 months 24 days ago
(08-Sep-2025)

0/5 (0%)

$8.2 (25.79%)

Buy

$52

$19.08 (57.96%)

$48

11 months 21 days ago
(11-Nov-2024)

0/2 (0%)

$24.25 (87.39%)

Buy

$39

$6.08 (18.47%)

$22

1 years 7 months 10 days ago
(22-Mar-2024)

2/2 (100%)

$7.06 (22.10%)

299

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DNTH (Dianthus Therapeutics) average time for price targets to be met?

On average it took 147 days on average for the stock forecasts to be realized with a an average price target met ratio 39.29

Which analyst has the current highest performing score on DNTH (Dianthus Therapeutics) with a proven track record?

MAURY RAYCROFT

Which analyst has the current lower performing score on DNTH (Dianthus Therapeutics) with a proven track record?

LELAND GERSHELL

Which analyst has the most public recommendations on DNTH (Dianthus Therapeutics)?

Maury Raycroft works at JEFFERIES and has 3 price targets and 2 ratings on DNTH

Which analyst is the currently most bullish on DNTH (Dianthus Therapeutics)?

Steven Seedhouse with highest potential upside - $30.08

Which analyst is the currently most reserved on DNTH (Dianthus Therapeutics)?

Maury Raycroft with lowest potential downside - $6.08

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?